HBK Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-144,300
Closed -$3.43M 755
2019
Q1
$3.43M Buy
+144,300
New +$3.29M 0.03% 400
2018
Q2
Sell
-251,000
Closed -$5.19M 1064
2018
Q1
$5.56M Buy
251,000
+230,603
+1,131% +$6.37M 0.04% 246
2017
Q4
$620K Buy
+20,397
New +$543K ﹤0.01% 701
2017
Q3
Sell
-70,537
Closed -$1.74M 1042
2017
Q2
$1.74M Buy
+70,537
New +$1.49M 0.01% 444
2017
Q1
Sell
-117,700
Closed -$1.75M 707
2016
Q4
$1.75M Buy
117,700
+37,600
+47% +$542K 0.02% 368
2016
Q3
$1.02M Buy
+80,100
New +$866K 0.01% 508

Other funds holding EXEL

HBK Investments's EXEL Position: Q2 2019 in Review

HBK Investments sold out of Exelixis (EXEL) in Q2 2019, closing a stake of 144,300 shares — an estimated $3.43M sold.

HBK Investments first reported a position in EXEL in Q3 2016 and held it in 6 quarters. The position peaked at $5.56M in Q1 2018. 346 funds tracked by Wall St. Rank hold EXEL as of Q2 2019.

  • HBK Investments reported no remaining Exelixis position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 144,300 Exelixis shares in Q2 2019, an estimated $3.43M.
  • HBK Investments first reported a position in Exelixis in Q3 2016 and held it in 6 quarters.
  • HBK Investments's Exelixis position peaked at $5.56M in Q1 2018.
  • 346 funds tracked by Wall St. Rank held Exelixis as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.